The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic
April 9, 2021
Tags:
Pierre Luzeau, Chief Executive Officer of Seqens, explains how the company is investing and growing to meet the challenges of the future of small molecule manufacturing.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
.svg)
